Christopher David Snook
Director/Board Member at Sandoz Pharmaceuticals AG
Profile
Christopher David Snook is currently a Director at Sandoz Pharmaceuticals AG and Alcon Canada, Inc. He was previously a Director and Head-Investor Relations at Pennant International Group Plc from 2000 to 2017.
Christopher David Snook active positions
| Companies | Position | Start |
|---|---|---|
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Director/Board Member | - |
Alcon Canada, Inc.
 Alcon Canada, Inc. Electronic ComponentsElectronic Technology Alcon Canada, Inc. engages in developing, manufacturing, and marketing eye care products and instrumentation. Its products include alcon surgical, alcon pharmaceutical and alcon vision care products. The company is headquartered in Mississauga, Canada. | Director/Board Member | - |
Former positions of Christopher David Snook
| Companies | Position | End |
|---|---|---|
| PENNANT INTERNATIONAL GROUP PLC | Chief Executive Officer | 2017-02-20 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PENNANT INTERNATIONAL GROUP PLC | Technology Services |
| Private companies | 2 |
|---|---|
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Alcon Canada, Inc.
Alcon Canada, Inc. Electronic ComponentsElectronic Technology Alcon Canada, Inc. engages in developing, manufacturing, and marketing eye care products and instrumentation. Its products include alcon surgical, alcon pharmaceutical and alcon vision care products. The company is headquartered in Mississauga, Canada. | Electronic Technology |
- Stock Market
- Insiders
- Christopher David Snook
